EEG abnormalities in clozapine-treated schizophrenic patients

Area of Science:

• Neuroscience
• Psychiatry
• Clinical Electrophysiology

Background:

• Clozapine is an effective treatment for refractory schizophrenia.
• Schizophrenia is associated with various neurological abnormalities.
• The impact of clozapine on electroencephalogram (EEG) findings requires further investigation.

Purpose of the Study:

• To investigate EEG changes in patients with refractory schizophrenia during clozapine treatment.
• To determine the incidence of EEG abnormalities and clinical seizures.
• To explore the relationship between EEG findings, clinical response, and disease duration.

Main Methods:

• Prospective study design.
• Electroencephalogram (EEG) recordings performed before and during clozapine treatment (300 mg/day).
• Assessment of clinical response and seizure occurrence in 11 patients completing the study.

Main Results:

• EEG abnormalities were observed in 64% (7/11) of patients completing the study.
• Generalized slowing was the most frequent abnormality (6/11), followed by epileptic activity (2/11).
• No clinical seizures were reported in any patient during the study.

Conclusions:

• EEG abnormalities are frequent in patients with refractory schizophrenia treated with clozapine.
• Observed EEG changes do not appear to predict the occurrence of clinical seizures.
• Further research is needed to understand the clinical significance of these EEG alterations.